Celcuity Inc.

Filed a patent for "methods of preparing a primary cell sample" on Thu, July 27, 2023

Filed a patent for "methods of measuring signaling pathway activity for selection of therapeutic agents" on Thu, April 27, 2023

Filed a patent for "methods of treating cancer patients with ras node or rtk targeted therapeutic agents" on Thu, December 29, 2022

Filed a patent for "methods for the treatment of cancer using 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea" on Thu, January 26, 2023